Table:
p.A143T Fabry patients	Missense mutation patients
Total (n = 25)	Female (n = 15)	Male (n = 10)	Total (n = 58)	Female (n = 39)	Male (n = 19)
gastrointestinal pain, n	12 (48.0)	8 (53.3)*	4 (40.0)	11 (20.0)	6 (16.2)	5 (27.8)
diarrhea, n	8 (32.0)	6 (40.0)**	2 (20.0)	5 (9.1)	2 (5.4)	3 (16.7)
tinnitus, n	7 (29.2)	4 (28.6)	3 (30.0)	6 (10.7)	6 (16.2)	0 (0.0)
neuropathic pain, n	7 (28.0)	4 (26.7)	3 (30.0)	26 (45.6)	18 (47.4)	8 (42.1)
hypohidrosis, n	6 (24.0)	4 (26.7)	2 (20.0)	18 (32.1)	11 (29.0)	7 (38.9)
fatigue, n	5 (20.0)	4 (26.7)	1 (10.0)	10 (18.9)	8 (23.5)	2 (10.5)
hypacusis, n	3 (12.5)	1 (7.1)	2 (20.0)	5 (8.8)	5 (13.2)	0 (0.0)
dyspnea, n	3 (12.0)	3 (20.0)	0 (0.0)	12 (21.1)	8 (21.1)	4 (21.1)
edema, n	1 (4.2)	1 (6.7)	0 (0.0)	2 (3.6)	0 (0.0)	2 (10.5)
cornea verticillata, n	0 (0.0)	0 (0.0)	0 (0.0)	9 (19.6)	8 (29.6)*	1 (5.3)
LVEF, %	63.1 ± 6.4	60.9 ± 6.2	66.2 ± 5.6	63.2 ± 9.6	64.5 ± 9.8	60.6 ± 8.8

Continue parse the table with markdown style: |  | <COLSPAN=3> p.A143T Fabry patients | <COLSPAN=3> Missense mutation patients | 
 |  | Total (n = 25) | Female (n = 15) | Male (n = 10) | Total (n = 58) | Female (n = 39) | Male (n = 19) | 
 | --- | --- | --- | --- | --- | --- | --- | 
 | gastrointestinal pain, n | 12 (48.0) | 8 (53.3)* | 4 (40.0) | 11 (20.0) | 6 (16.2) | 5 (27.8) | 
 | diarrhea, n | 8 (32.0) | 6 (40.0)** | 2 (20.0) | 5 (9.1) | 2 (5.4) | 3 (16.7) | 
 | tinnitus, n | 7 (29.2) | 4 (28.6) | 3 (30.0) | 6 (10.7) | 6 (16.2) | 0 (0.0) | 
 | neuropathic pain, n | 7 (28.0) | 4 (26.7) | 3 (30.0) | 26 (45.6) | 18 (47.4) | 8 (42.1) | 
 | hypohidrosis, n | 6 (24.0) | 4 (26.7) | 2 (20.0) | 18 (32.1) | 11 (29.0) | 7 (38.9) | 
 | fatigue, n | 5 (20.0) | 4 (26.7) | 1 (10.0) | 10 (18.9) | 8 (23.5) | 2 (10.5) | 
 | hypacusis, n | 3 (12.5) | 1 (7.1) | 2 (20.0) | 5 (8.8) | 5 (13.2) | 0 (0.0) | 
 | dyspnea, n | 3 (12.0) | 3 (20.0) | 0 (0.0) | 12 (21.1) | 8 (21.1) | 4 (21.1) | 
 | edema, n | 1 (4.2) | 1 (6.7) | 0 (0.0) | 2 (3.6) | 0 (0.0) | 2

(10.5) | 
 | cornea verticillata, n | 0 (0.0) | 0 (0.0) | 0 (0.0) | 9 (19.6) | 8 (29.6)* | 1 (5.3) | 
 | LVEF, % | 63.1 ± 6.4 | 60.9 ± 6.2 | 66.2 ± 5.6 | 63.2 ± 9.6 | 64.5 ± 9.8 | 60.6 ± 8.8 |